Skip to main content

Table 2 Demographic and clinicopathologic characteristics of the patients who underwent open and laparoscopic surgery

From: Short-term outcomes of open versus laparoscopic surgery in patients with metachronous colorectal cancer

 

Open surgery

Laparoscopic surgery

P value

(n = 34)

(n = 25)

Gender (%)

  

0.284

 Male

26 (76.5)

15 (60.0)

 

 Female

8 (23.5)

10 (40.0)

 

Age at surgery

(years), mean ± SD

61.26 ± 12.00

61.96 ± 13.95

0.838

BMI

(kg/m2), mean ± SD

24.87 ± 3.69

23.98 ± 2.71

0.313

ASA score (%)

  

0.184

 II

25 (73.5)

23 (92.0)

 

 III

8 (23.5)

2 (8.0)

 

 IV

1 (2.9)

0 (0.0)

 

Year of surgery (%)

  

0.229

 1980–2010

2 (5.9)

0 (0.0)

 

 2010–2020

30 (88.2)

21 (84.0)

 

 2020-present

2 (5.9)

4 (16.0)

 

Type of previous operation (%)

  

 < 0.001

 Open surgery

31 (91.2)

6 (24.0)

 

 Laparoscopic surgery

3 (8.8)

19 (76.0)

 

History of other abdominal surgery (%)

  

0.222

 No

26 (76.5)

23 (92.0)

 

 Yes

8 (23.5)

2 (8.0)

 

Preoperative chemotherapy(%)

  

0.619

 No

17 (50.0)

15 (60.0)

 

 Yes

17 (50.0)

10 (40.0)

 

Preoperative radiotherapy(%)

  

1.000

 No

28 (82.4)

21 (84.0)

 

 Yes

6 (17.6)

4 (16.0)

 

Interval between operations

(months), mean ± SD

92.65 ± 103.50

94.68 ± 114.76

0.943

 Tumor location (%)

  

0.375

 Right colon

11 (32.4)

5 (20.0)

 

 Left colon

10 (29.4)

6 (24.0)

 

 Rectum

13 (38.2)

14 (56.0)

 

Tumor size

(cm), mean ± SD

4.31 ± 3.03

3.11 ± 1.68

0.078

Gross classification (%)

  

0.115

 Mass type

24 (70.6)

15 (60.0)

 

 Ulceration type

7 (20.6)

10 (40.0)

 

 Infiltration type

3 (8.8)

0 (0.0)

 

Differentiation (%)

  

1.000

 p/d

8 (23.5)

6 (24.0)

 

 w/d, m/d

26 (76.5)

19 (76.0)

 

T stage (%)

  

0.121

 1

6 (17.6)

9 (36.0)

 

 2

5 (14.7)

7 (28.0)

 

 3

13 (38.2)

5 (20.0)

 

 4

10 (29.4)

4 (16.0)

 

N stage (%)

  

0.414

 0

25 (73.5)

15 (60.0)

 

 1,2

9 (26.5)

10 (40.0)

 

M stage (%)

  

NA

 0

34 (100.0)

25 (100.0)

 

 1

0 (0.0)

0 (0.0)

 

TNM stage (%)

  

0.414

 I,II

25 (73.5)

15 (60.0)

 

 III

9 (26.5)

10 (40.0)

 
  1. SD Standard deviation, BMI Body mass index, ASA Score American Society of Anesthesiologists classification score, p/d Poorly differentiated, w/d Well differentiated, m/d Moderately differentiated, NA Not applicable